Chaga Mushroom: Benefits, Research & Safety

Chaga (Inonotus obliquus) is a woody fungus that grows mainly on birch trees in cold northern regions. It has long been used as a folk tea and is now sold as powders, extracts and capsules. People take it hoping for antioxidant and immune support, but human research is very limited.

Chaga Mushroom Ingredient Guide

Also known as: Chaga, Inonotus obliquus, Birch conk, Clinker polypore, Cinder conk

What it is
Chaga is the hard, dark, charcoal-like growth (a sclerotium) of the fungus Inonotus obliquus, found mostly on birch trees. It contains polysaccharides, triterpenoids such as inotodiol and betulinic acid, and polyphenols.
What it does
In laboratory and animal studies, chaga compounds showed antioxidant, anti-inflammatory and immune-modulating activity. Whether these effects occur in people at supplement amounts has not been established.
How it is used
Chaga is traditionally simmered as a tea or decoction. Today it is also taken as powder, capsules or liquid extracts, often alone or blended with other mushrooms.
Natural sources and forms
It comes from wild-harvested or cultivated chaga, usually as dried powder, hot-water extract or alcohol (dual) extract. Standardization is inconsistent, and the chemical content varies with the source and the extraction method.
Why it appears in formulas
Makers add chaga because of its reputation as an antioxidant-rich traditional mushroom, and to support the appeal of "adaptogen" or wellness blends. Marketing often outpaces the human evidence.
What to know before use
Chaga can be very high in oxalate, and case reports link long-term heavy use to serious kidney injury. People with kidney problems, on blood thinners or on diabetes medicines should talk to a clinician first.

What the Research Says

Overall: Early evidence

Nearly all of the research on chaga comes from test-tube and animal studies. Those studies looked at antioxidant, anti-inflammatory, blood sugar, cholesterol and anti-tumor effects of chaga extracts and of isolated compounds such as betulinic acid and inotodiol.

Reviews of the field note that controlled human trials are scarce, small or missing. Memorial Sloan Kettering's integrative medicine service states that the safety and effectiveness of chaga have not been evaluated in clinical studies. Reviews also point to chemical variability between products and a lack of robust clinical validation as barriers to standardized use.

The human safety literature is mostly case reports. These describe oxalate nephropathy, a form of kidney damage, in people who took chaga powder over long periods. Those reports are not controlled data, but they are a consistent warning signal.

In short, laboratory results are interesting, but they cannot be assumed to apply to people. Claims that chaga prevents or treats cancer, diabetes or any other disease are not supported by good human evidence.

Studied forWhat the research saysEvidence
Antioxidant activityChaga extracts show strong antioxidant activity in test tubes and in animal studies. This does not show a health benefit in people.Early evidence
Immune and inflammation markersCell and animal studies suggest chaga polysaccharides and triterpenoids may influence immune cells and inflammatory signaling. Good human trials are lacking.Early evidence
Blood sugar and cholesterolAnimal studies of chaga and betulinic acid report lower blood sugar and lipids. Human evidence is not established, and chaga may add to the effect of diabetes medicines.Early evidence
Cancer cellsExtracts have reduced growth of some cancer cell lines in the lab, including prostate and breast cells. Clinical effectiveness in people has not been shown.Early evidence

Did you know? A fungus that looks like charcoal

Chaga is not a typical mushroom cap. It is a hard, black, cracked mass that looks like burnt charcoal, with a rusty-orange interior. It grows slowly on living birch trees, and traditional preparations simmered it into a dark tea.

Amounts Used in Studies

These are amounts researchers used, not dosing advice. Ask your doctor or pharmacist what is right for you.

FormAmountStudy context
Hot-water or alcohol extracts in animal and cell studiesVaries widely; no established human amountMostly preclinical research, so these amounts cannot be applied to people
Chaga powder in kidney injury case reportsReported long-term daily intake, often several grams or more a dayCases of oxalate nephropathy; this is a harm signal, not a studied benefit

Safety, Side Effects and Interactions

There is no well-established safe amount of chaga for people, and long-term safety data are limited.

The main concern is kidney damage. Chaga can contain a lot of oxalate, and in one case report the leftover powder measured about 14 g of oxalate per 100 g. Several case reports, mostly from Korea and Japan, describe oxalate nephropathy after weeks to years of regular chaga powder or tea use. Some people needed dialysis, and at least one progressed to end-stage kidney disease. Oxalate crystals are not removed well by dialysis.

Chaga may also affect bleeding and blood sugar, based on secondary summaries and limited data. Other reported effects are digestive upset, though these are not well documented. Allergic reactions are possible with any mushroom product. Because products vary and wild-harvested chaga is not standardized, contents can differ from the label.

Stop use and seek care if you notice swelling, reduced urination, or other signs of kidney trouble.

Possible interactions

  • Blood thinners such as warfarin and antiplatelet drugs: chaga may raise bleeding risk, according to Memorial Sloan Kettering.
  • Diabetes medicines, including insulin: chaga may lower blood sugar further, so glucose could drop too low.
  • Medicines that can stress the kidneys, such as NSAIDs, may add to kidney risk when combined with high-oxalate chaga.
  • Immunosuppressants: chaga may affect immune activity, so ask a pharmacist or doctor.

Avoid it or ask a doctor first if

  • Kidney disease or a history of kidney stones, especially oxalate stones
  • Taking blood thinners or antiplatelet drugs
  • Taking diabetes medicines or having blood sugar problems
  • Planned surgery within about 2 weeks
  • Pregnant or breastfeeding, because safety data are lacking
  • Autoimmune disease or organ transplant
  • Allergy to mushrooms

Supplements We've Reviewed That Contain Chaga Mushroom

Each review checks the full formula, price, refund policy and side effects.

Frequently Asked Questions About Chaga Mushroom

Does Chaga Mushroom really work?

There is not enough human research to say. Most findings come from cell and animal studies on antioxidant, immune and blood sugar effects. Controlled human trials are scarce, so benefits are unproven.

Is Chaga Mushroom safe?

Occasional use in small amounts may be tolerated by many healthy people, but long-term safety is not established. Case reports link heavy, long-term use to oxalate kidney damage. It can also interact with blood thinners and diabetes drugs, so check with a clinician first.

Why does chaga raise kidney concerns?

Chaga can contain very high levels of oxalate. When oxalate builds up in the kidneys, it can form crystals and injure kidney tissue. Case reports describe this after prolonged use of chaga powder.

Is chaga tea the same as chaga extract?

Not exactly. Tea or hot-water extracts pull out different compounds than alcohol extracts or whole powder. Strength and oxalate content vary by product, and labels rarely give full details.

Can chaga treat or prevent cancer?

No. Lab studies show effects on cancer cells, but this has not been shown in people. Anyone with cancer should discuss chaga with their oncology team before using it.

Sources

  1. Chaga Mushroom — Memorial Sloan Kettering Cancer Center
  2. Chaga mushroom-induced oxalate nephropathy that clinically manifested as nephrotic syndrome: A case report — PubMed
  3. Development of End Stage Renal Disease after Long-Term Ingestion of Chaga Mushroom: Case Report and Review of Literature — PubMed
  4. A brief overview of the medicinal and nutraceutical importance of Inonotus obliquus (chaga) mushrooms — PubMed Central

Last reviewed: